Monday 8 April 2013

Microbial Risk in Pharmaceutical Manufacturing and ICH Q9



The current PDA Journal has an interesting article titled 'Microbial Risk in Pharmaceutical Manufacturing and ICH Q9', written by Dennis E. Guilfoyle, Richard L. Friedman, Patricia F. HughesDavid HussongAmy S. Rosenberg and Kurt Brorson.

The article addresses the key risk based assessment criteria that pharmaceutical microbiologists and those tasked with contamination control should be aware of.

The article is currently free to read and to download.

PDA Journal of Pharmaceutical Science and Technology vol. 67 no. 2 79-80   

For more details, see the PDA Journal.                                  

Posted by Tim Sandle

1 comment:

  1. It is an important issue since the are notable numbers of pharmaceutical companies over the world.

    ReplyDelete

Pharmaceutical Microbiology Resources

Special offers